top of page

Brand Change: testosterone undecanoate inj 250 mg per ml, (Reandron) to new brand (Gonadron)

  • 2 hours ago
  • 1 min read


Brand change:

 

We are writing to inform you of a brand change for testosterone undecanoate inj 250 mg per ml, (Reandron)

 

Key Dates:


  • The Gonadron brand of testosterone undecanoate inj 250 mg per ml is to be listed (funded) from 1 June 2026 on the Community Schedule and in Health NZ hospitals.

  • Testosterone undecanoate inj 250 mg per ml (Reandron) brand will be delisted (no longer funded) 1 November 2026.

  • The active ingredients and excipients are the same as the Reandron brand.

  • For more information about this change see Testosterone injection on Pharmac website

 

Questions: 

If you have any queries, please contact us at enquiry@pharmac.govt.nz

 

Please share this information:


Please share this information with your colleagues and within your networks.


Ngā mihi,

 

Anna I Senior Advisor Implementation

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz

bottom of page